Recomendation
Upon the recommendation of the FDA (Food and Drug Administration), all drugs containing phenylpronalamine should be withdrawn from the U.S. market. This decision was based on a study conducted to investigate the risk of hemorrhagic stroke associated with the use of phenylpronalamine. The study reported an association between phenylpronalamine use and hemorrhagic stroke in women. The increase risk of hemorrhagic stroke was for women using phenylpronalamine for weight control and as a nasal decongestant product. Although the study showed that the risk of hemorrhagic stoke is found mostly in women, men may also be at risk.
The following is a list of all drugs containing phenylpronalamine that are still available and in use in the Egyptian market:
1. Conta-Flu
2. Antiflu
3. Nova-C-M
4. Coldact
5. Flustop
6. Flurest
7. Rhinomol
8. Pararhinol
9. Michaelon
10. Noflu
11. Coricidin D
12. Rhinogesic
13. Contact 12
14. Eskornade
15. Night and Day
16. Vegaskine Aduls Syrup
17. Sinutab
18. Rhinopront Syrup
19. Denoral
20. Coflin
Please, avoid using the above drugs even if prescribed by your treating physician.
2. Right-Click then Copy
3. Paste the HTML code into your webpage
Related posts:
